Authors : Natasha Radhakrishnan, Natasha Radhakrishnan, Gopal S Pillai, Gopal S Pillai, Aishwarya Iyer, Aishwarya Iyer
DOI : 10.18231/j.ijooo.2022.046
Volume : 8
Issue : 3
Year : 2022
Page No : 205-209
Purpose: To identify baseline qualitatative OCT biomarkers that can predict good visual outcome in diabetic macular edema after treatment.
Study design: Prospective, observational study in the time period.
Materials and Methods: We included 37 eyes of 37 patients with treatment naïve diabetic macular edema who subsequently underwent treatment with injections of intravitreal Ranibizumab. Inclusion criteria was: Presenting vision < 0>250 microns). 3 injections were given monthly irrespective of treatment response followed by PRN dosing. Factors under evaluation were: 1) Submacular detachment (SMD) (2) cystoid changes in the inner and outer nuclear layer (4) Integrity of IS-OS junction. (5) Hyper Reflective Foci(HRF) and location (6) vitreomacular interface (7) Disruption of inner retinal layers(DRIL)
Results: We included 37 eyes in our study. For analysis, based on final visual acuity patients were divided in two groups: (1) Group A: Good visual acuity (>10 ETDRS letter gain) and (2) Group B: Poor visual outcome (< 10>
Conclusion: Presence of SMD was found to have most significance in predicting good visual acuity response to anti VEGF.DRIL was found to decrease during the treatment but a predictive role could not be demonstrated.
Keywords: Diabetic maculopathy, Diabetic macular edema, OCT biomarkers